Download Complementary and alternative medicines in prostate cancer: by K. B. Harikumar PDF

By K. B. Harikumar

Recent worldwide melanoma statistical info has truly indicated that prostate melanoma is presently the second one most often clinically determined melanoma (at 15% of all male cancers) and globally the 6th best reason behind melanoma loss of life in men. This publication is a precis of prostate melanoma, masking its prevalence, epidemiology, and present therapies. It additionally serves as an up to date assessment of the prestige of presently to be had substitute and complementary drugs for treating prostate melanoma, together with numerous plant extracts, natural formulations, common items, yoga, acupuncture, Ayurveda, homeopathy, and Siddha medicinal drugs utilized in prostate melanoma therapy.

Show description

Read or Download Complementary and alternative medicines in prostate cancer: a comprehensive approach PDF

Best cancer books

Cancer Prevention: The Causes and Prevention of Cancer Volume 1 (Cancer Prevention-Cancer Causes)

This quantity, the 1st within the new sequence melanoma Prevention - melanoma factors, is derived from the first and 2d reviews of the Harvard middle for melanoma Prevention released in melanoma factors and keep an eye on, 1996; 7(Suppl 1) and 1997; 8(Suppl 2), respectively. during this quantity we extend on fabrics to summarize the facts on explanations of melanoma and to set forth a sequence of recommendations to advertise the prevention of melanoma.

Innate Immune Regulation and Cancer Immunotherapy

Innate and adaptive immunity play vital roles in immunosurveillance and tumor destruction. despite the fact that, expanding facts means that tumor-infiltrating immune cells can have a twin functionality: inhibiting or selling tumor progress and development. even if regulatory T (Treg) cells set off immune tolerance through suppressing host immune responses opposed to self- or non self-antigens, therefore taking part in severe roles in combating autoimmune ailments, they may inhibit antitumor immunity and advertise tumor progress.

Metabolic Masterpiece

Metabolic Masterpiece is a 12 Week physique Sculpting exercise routine application Designed To Burn fats, construct Muscle, and Get You Ripped! certain Bonus: Renaissance part Scotts magazine.

Advances in Cancer Research

Advances in melanoma examine offers precious details at the interesting and fast-moving box of melanoma study, featuring notable and unique studies on a number of themes. offers details on melanoma researchOutstanding and unique reviewsSuitable for researchers and scholars

Additional resources for Complementary and alternative medicines in prostate cancer: a comprehensive approach

Sample text

2015). 1 per 100,000). , 2013). In the United States, the highest incidence rate of prostate cancer from 2006 to 2010 was in California, which had 23,010 cases per 100,000 during that period. It was also high in Florida (16,590 per 100,000), Texas (15,900 per 100,000), and New York (15,440 per 100,000). The lowest incidences were in North Dakota (460 per 100,000), Wyoming (490 per 100,000), and the District of Columbia (510 per 100,000) (Siegel et al. 2014). 1 per 100,000, respectively. , 2010).

MRI scans of the prostate are becoming increasingly accurate in identifying the prostatic tumors, mostly because of the advent of diffusion-weighted imaging (DWI) (Rosenkrantz and Taneja, 2015). DRE involves insertion of a gloved and lubricated finger into the rectum followed by feeling the gland to examine for a palpable tumor. Tumors detected by DRE are usually advanced (Hoffman, 2015). Biopsy is performed currently by ultrasound-guided transrectal or transperineal lateraldirected 18G core biopsy.

MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem 288(11), 7986–7995. Ren, S. Liu, Y. Xu, W. et al. 2013. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol 190(6), 2278–2287. N. M. L. et al. 2014. Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol 232(2), 178–184. J. R. S. et al. 2013. Abiraterone in metastatic prostate cancer without previous chemotherapy.

Download PDF sample

Rated 4.17 of 5 – based on 29 votes